Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr. Vanessa Naguleswaran

Dr. Vanessa Naguleswaran

Pediatric Registrar,Basildon Hospital UK

Marja T Nevalainen

Marja T Nevalainen

Director Wisconsin University USA

Magnus S Magnusson

Magnus S Magnusson

Director University of Iceland, Iceland

Kwok-nam Leung

Kwok-nam Leung

The Chinese University of Hong Kong (CUHK), Hong Kong

Zhi Ping Xu

Zhi Ping Xu

University of Queensland Australia

Benjamin Deneen

Benjamin Deneen

Ph.D. and Professor at UCLA USA

Shannon Miller

Shannon Miller

Empowerment Coach. and Cancer Survivor and Cancer Research Speaker USA

Kathryn Allen

Kathryn Allen

Executive Director, Science and Public Affairs Speakers World Cancer Research Fund International UK

Pediatric Cancer Congress 2024

About conference

Speaker Registration 20% Discount till July 20, 2024

The "25th World Congress on Pediatric Oncology and Cancer Care" is scheduled to be held in Paris , France from September 19-20, 2024, with a focus on the theme "Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports." The event will encompass keynote speeches, poster presentations, oral lectures, and exhibitions, creating a comprehensive platform for discussion and learning on diverse topics related to cancer, such as Cancer Biomarkers, Anti-Cancer drug discovery therapy, Gynaecologic Oncology, Immuno Oncology, Neuro Oncology, Oncology Nursing, Pediatric Oncology, Pulmonary Oncology, Surgical Oncology, Cancer and Oncology Genetics, among others. The Pediatric Cancer Congress stands as a global platform, initiated by Conference Series, bringing together experts from both industry and academia.

Group Registration 50% Discount

The conference offers an opportunity for young researchers and students to explore the presented research on pediatric cancer across various scientific disciplines. The overarching aim of Pediatric Cancer Congress 2024 is to disseminate essential knowledge in the medical and life sciences, vital for researchers in their respective fields. Given this objective, Germany is chosen as the ideal location for the exchange of information.
 
Pediatric Cancer Congress 2024 serves as a global forum for the presentation of cutting-edge research methodologies, innovative devices, and newly introduced drugs for pediatric and neonatal oncology. By fostering discussions on diverse topics within this domain, the conference contributes to knowledge dissemination and aims to reduce the global incidence rate of pediatric cancer. Each conference features several expert speakers, addressing various oncology-related subjects. The daily schedule of the Pediatric Oncology Congress includes numerous topic analyses, allowing participants to choose their preferred topics from the global events.
 
One of the key objectives of Pediatric Cancer Congress 2024 is to honor deserving young researchers, scientists, investigators, post-graduate students, post-doctoral fellows, trainees, and junior professors for their outstanding contributions to the conference theme. The Young Scientist Awards are designed to provide early-career academicians with a valuable professional development opportunity by facilitating the exchange of expertise on all aspects of cancer care and oncology.
 
For the 2024 nominations, the Pediatric Cancer Congress is organizing the Young Researcher Forum, which will only accept 20 presentations for Outstanding Masters/Ph.D./Post Doctorate thesis work. Participants in the Young Scientist Award category will receive certificates of achievement and souvenirs. The conference offers an excellent venue for the oral presentation of research, providing opportunities for networking, collaboration, and exposure to new technologies and employment opportunities. Additionally, the event serves as a valuable platform for young researchers to expand their knowledge across different study fields through interactions with renowned senior researchers from around the globe, particularly in the field of nanotechnology.
 

why to attend

The Pediatrics congress 2024 represents a unique and exciting interdisciplinary opportunity that provides a broad opportunity to showcase cutting-edge technologies, new products and services tailored to a broad global audience in the field. Participants will take advantage of an excellent opportunity to showcase the latest advances in pediatric cancer and oncology while providing comprehensive coverage of a wide range of topics. 
 
Expected to attract over 200 participants from around the world, the 2024 Pediatric Cancer Congress  promises to feature thought-provoking keynote lectures, oral presentations and poster sessions  from global experts in  medicine, health care and oncology. Delegates will include members of the editorial boards of relevant international publications. 
 
 A cost-effective marketing strategy for increasing sales, opportunities and contacts, business networking provides suppliers with a unique opportunity to connect with “leading scientists and peers.” The conference actively encourages participation from students and recent graduates through a special student poster contest and encourages the exhibition of unique research for publication in future journals. A poster session during the conference will feature all submitted abstracts. Students who are unable to physically attend may submit an electronic poster for a nominal fee of $99, which guarantees online publication of the paper with a DOI. Adding live streaming is an additional service for presenters. 
 
 Target audience: 
 
The conference is designed for a diverse audience:
  •      Physicians,
  •      Early career scientists,
  •      Medical schools
  •      Pediatric cancer societies
  •      Medical device  companies,
  •      Medical professionals
  •      Medical directors,
  •      Oncologists,
  •      Medical and pharmaceutical professionals
  •      Academic researchers. 
  •      Postdoctoral researcher.
  •      Students, researchers, managers and business representatives. 
 
 More than 300 participants (70% from industry, 30% from academia) 
 A lineup of over 5 keynote speakers, over 50  plenary speakers, and over 20 diverse exhibitors. 
 Over 5 masterclasses, 14 creative training sessions and business meetings. 
 The joy of attending Children's Oncology Congress 2023 lies in the opportunity to improve and progressively advance your surgical skills, as well as  gain a broader perspective through training and industry reviews.

Participant Benefits

  • All programs entry
  • Reception banquet
  • 2 Coffee breaks and snacks during the two days
  • Handbook
  • Lunch during the conference
  • Conference souvenir
  • Abstracts will be published in our referred journal
  • 25% Discount on the manuscript publication fee
  • Certification by the organizing committee
  • Wi-Fi facility
  • CME-CPD Credits
  • 50% Discount for group of 10 members
  • Localities Participation Benefits:
  • 20% Discount will be provided for the participants, who are attending from the local universities and hospitals.

Market Analysis

Market Analysis of Pediatric Oncology and Cancer Care (2016-2024)

Over the past eight years, the pediatric oncology and cancer care market has undergone significant transformation and expansion, driven by technological advancements, increased funding, heightened awareness, and innovative research. This period has been marked by notable improvements in treatment modalities, a deeper understanding of pediatric cancers, and a concerted effort to enhance the quality of life and survival rates for young patients.

Technological and Treatment Advancements

One of the most significant advancements in pediatric oncology has been the development and application of immunotherapy treatments. Immunotherapies, particularly CAR-T cell therapy, have revolutionized the treatment landscape for certain types of leukemia and lymphoma. CAR-T cell therapy, which involves modifying a patient's T-cells to attack cancer cells, has shown remarkable efficacy, even in cases where traditional treatments have failed. Additionally, advancements in precision medicine have allowed for treatments to be tailored based on the genetic makeup of individual tumors, leading to more effective and less toxic treatment protocols. Precision medicine involves comprehensive genomic profiling of tumors, enabling oncologists to identify specific mutations and select targeted therapies that are more likely to be effective.

Minimally invasive surgical techniques have also improved outcomes for pediatric cancer patients. These techniques reduce recovery times and minimize surgical trauma, which is particularly beneficial for young patients. Innovations such as laparoscopic and robotic-assisted surgeries have become more prevalent, allowing for precise removal of tumors with reduced postoperative complications.

Research and Funding

Increased research funding has been a critical driver of advancements in pediatric oncology. Government initiatives, non-profit organizations, and pharmaceutical companies have all played significant roles in this regard. The National Institutes of Health (NIH) and other governmental bodies have provided substantial grants for pediatric cancer research. Non-profit organizations, such as the St. Baldrick's Foundation, have also been pivotal in raising funds and supporting research initiatives.

Market Segmentation and Regional Analysis

The pediatric oncology market can be segmented by cancer type, treatment type, and end-user. By cancer type, the market includes leukemia, brain and central nervous system tumors, neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, and others. Leukemia remains the most common type of cancer in children, with significant advancements in its treatment contributing to improved survival rates. Brain and central nervous system tumors are the second most common type, with ongoing research into targeted therapies showing promise. Neuroblastoma, a cancer that originates in immature nerve cells, has seen improved outcomes due to advances in immunotherapy and precision medicine.

By treatment type, the market includes chemotherapy, radiation therapy, surgery, stem cell transplantation, targeted therapy, and immunotherapy. Chemotherapy, despite its side effects, remains a cornerstone of pediatric cancer treatment. Radiation therapy has seen improvements in precision, reducing damage to healthy tissues. Surgery, particularly minimally invasive techniques, plays a crucial role in the management of solid tumors. Stem cell transplantation is used for certain types of cancers and has seen advancements that improve success rates. Targeted therapy and immunotherapy are rapidly growing segments, driven by continuous research and development.

Challenges and Future Outlook

Despite the advancements, the pediatric oncology market faces several challenges. High treatment costs remain a significant barrier, particularly in low- and middle-income countries. The cost of advanced treatments like CAR-T cell therapy can be prohibitive, limiting access for many patients. Additionally, geographic and economic disparities can restrict access to the latest treatments and clinical trials, underscoring the need for more equitable healthcare solutions.

The psychosocial impact of pediatric cancer on patients and their families is another significant challenge. Comprehensive support services, including psychological counseling and social support, are essential to address the emotional and psychological needs of young patients and their families.

Past conference

The overarching goal of Pediatric Cancer Congress 2023 is to confer honorary awards to deserving young researchers, scientists, young investigators, post-graduate students, post-doctoral fellows, trainees, and junior professors, acknowledging their outstanding contributions to the conference theme. The Young Scientist Awards aim to provide early-career academicians with a robust professional development opportunity, fostering the exchange of expertise on all facets of cancer care and oncology.

Important guidelines

Final Paper Submission Deadline: 01 September, 2024

Early Bird Registration Deadline: 28 July, 2024
Notification of Abstract Acceptance/ Rejection: 1-2 days.

Conference Dates: 19-20 September, 2024

Group registration (Minimum 5 members) can avail 20% waivers from the registration fee.

Email: Program Manager at [email protected] or WhatsApp at (+44) - 7915641825 with details of the 5 participants

Abstract submission guidelines for Paediatrics Cancer Congress 2024 conferences:

  • If you choose to participate in this conference, you need to submit an abstract
  • The abstract should carry the summary of a research
  • Abstract should be submitted either through e-mail or using the link given below
  • Abstracts should be based on any areas as listed in this website as sessions/tracks

To Collaborate Scientific Professionals around the World

Conference Date September 19-20, 2024

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Pediatric Blood & Cancer Journal of Cancer Research and Clinical Oncology Journal of Pediatric Hematology/ Oncology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner